Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder

Conditions:   Sjogren's Syndrome;   Overactive Bladder Syndrome Interventions:   Drug: mirabegron;   Drug: oxybutynin, tolterodine, solifenacin Sponsor:   China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials